Skip to content
Disclosery

EXANE DERIVATIVES: CLH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CLH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 5,986 CLH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 5,986 shares
    Change vs previous 13F -7,082 shares

    0.3% of the 13F portfolio, value $524,686.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 13,068 shares
    Change vs previous 13F +269 shares

    0.41% of the 13F portfolio, value $1,458,822.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 12,799 shares
    Change vs previous 13F +4,775 shares

    0.31% of the 13F portfolio, value $1,276,910.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 8,024 shares
    Change vs previous 13F -2,006 shares

    0.21% of the 13F portfolio, value $833,423.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 10,030 shares
    Change vs previous 13F not available

    0.22% of the 13F portfolio, value $924,945.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).